Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis

Mediators of Inflammation

Volumn 2005, Issue 6, 2005, Pages 390-394

  Kurutas, Ergul Belge ^a   Cetinkaya, Ali ^a   Bulbuloglu, Ertan ^a   Kantarceken, Bulent ^a  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETYLCYSTEINE; ANTIOXIDANT; CARNITINE; COPPER ZINC SUPEROXIDE DISMUTASE; MALONALDEHYDE; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; LEUKOCYTE; MALE; NEUTROPHIL; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; CARNITINE; COLITIS, ULCERATIVE; FREE RADICAL SCAVENGERS; LEUKOCYTES; MALE; MALONDIALDEHYDE; PEROXIDASE; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; VITAMIN B COMPLEX;

ANIMALIA;

EID: 29144454969     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/MI.2005.390     Document Type: Article

References (40)

1. Williams JG, Hughes LE, Hallett MB. Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut. 1990;31(2):187-193.
2. Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology. 1991;101(2):540-547.
3. Millar AD, Rampton DS, Chander CL, et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut. 1996;39(3):407-415.
4. Grisham MB, Gaginella TS, von Ritter C, Tamai H, Be RM, Granger DN. Effects of neutrophil-derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability. Inflammation. 1990;14(5):531-542.
5. Fridovich I. Oxygen radicals, hydrogen peroxide, and oxygen toxicity. In: Pryor WA, ed. Free Radicals in Biology. New York, NY: Academic Press; 1976:239-277.
6. Uchimura K, Nagasaka A, Hayashi R, et al. Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus. J Diabetes Complications. 1999;13(5-6):264- 270.
7. Esterbauer H, Cheeseman KH, Dianzani MU, Poli G, Slater TF. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by ADP-Fe2+ in rat liver microsomes. Biochem J. 1982;208(1):129-140.
8. Kikugawa K, Kojima T, Yamaki S, Kosugi H. Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylenediaminetetraacetic acid. Anal Biochem. 1992;202(2):249-255.
9. Aruoma OI, Wasil M, Halliwell B, Hoey BM, Butler J. The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects? Biochem Pharmacol. 1987;36(21):3739-3742.
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265-275.
11. Worthington Biochemical Corporation. Worthington Enzyme Manual. Lakewood, NJ: Worthington Biochemical Corporation; 1972.
12. Fridovich I. Superoxide radical: an endogenous toxicant. Annu Rev Pharmacol Toxicol. 1983;23:239-257.
13. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351-358.
14. Babbs CF. Oxygen radicals in ulcerative colitis. Free Radic Biol Med. 1992;13(2):169-181.
15. NietoN, TorresMI, FernandezMI, et al. Experimental ulcerative colitis impairs antioxidant defense system in rat intestine. Dig Dis Sci. 2000;45(9):1820-1827.
16. Yavuz Y, Yuksel M, Yegen BC, Alican I. The effect of antioxidant therapy on colonic inflammation in the rat. Res Exp Med (Berl). 1999;199(2):101-110.
17. Grisham MB, Yamada T. Neutrophils, nitrogen oxides, and inflammatory bowel disease. Ann N Y Acad Sci. 1992;664:103-115.
18. McKenzie SJ, Baker MS, Buffinton GD, Doe WF. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest. 1996;98(1):136-141.
19. Lih-Brody L, Powell SR, Collier KP, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci. 1996;41(10):2078-2086.
20. D'Odorico A, Bortolan S, Cardin R, et al. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol. 2001;36(12):1289-1294.
21. Ademoglu E, Erbil Y, Tam B, et al. Do vitamin E and selenium have beneficial effects on trinitrobenzene-sulfonic acid-induced experimental colitis. Dig Dis Sci. 2004;49(1):102-108.
22. Choudhary S, Keshavarzian A, Yong S, et al. Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats. Dig Dis Sci. 2001;46(10):2222-2230.
23. Dong WG, Liu SP, Yu BP, Wu DF, Luo HS, Yu JP. Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats. World J Gastroenterol. 2003;9(11):2533-2538.
24. Girgin F, Karaoglu O, Erkus M, et al. Effects of trimetazidine on oxidant/antioxidant status in trinitrobenzenesulfonic acid-induced chronic colitis. J Toxicol Environ Health A. 2000;59(8):641-652.
25. Kuralay F, Yildiz C, Ozutemiz O, et al. Effects of trimetazidine on acetic acid-induced colitis in female Swiss rats. J Toxicol Environ Health A. 2003;66(2):169-179.
26. Giancaterini A, Mingrone G, De Gaetano A, et al. Effects of propyonil-l-carnitine topical irrigation in distal ulcerative colitis: a preliminary report. Am J Gastroenterol. 2001;96(7):2275-2276.
27. Gasbarrini G, Mingrone G, Giancaterini A, et al. Effects of propionyl-L-carnitine topical irrigation in distal ulcerative colitis: a preliminary report. Hepatogastroenterology. 2003;50(53):1385-1389.
28. Cetinkaya A, Bulbuloglu E, Kurutas EB, Ciralik H, Kantarceken B, Buyukbese MA. Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats. Tohoku J Exp Med. 2005;206(2):131-139.
29. Grisham MB, Benoit JN, Granger DN. Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol. 1990;186:729-742.
30. Sekizuka E, Grisham MB, Li MA, Deitch EA, Granger DN. Inflammation-induced intestinal hyperemia in the rat: role of neutrophils. Gastroenterology. 1988;95(6):1528-1534.
31. Cao YB, Zhang JD, Diao YY, et al. Effects of Changtai granules, a traditional compound Chinese medicine, on chronic trinitrobenzene sulfonic acid-induced colitis in rats. World J Gastroenterol. 2005;11(23):3539-3543.
32. Al Moutaery A. Proglumide attenuates experimental colitis in rats. Exp Toxicol Pathol. 2005;56(4-5):327-332.
33. Liu SP, Dong WG, Wu DF, Luo HS, Yu JP. Protective effect of angelica sinensis polysaccharide on experimental immunological colon injury in rats. World J Gastroenterol. 2003;9(12):2786-2790.
34. Shusterman T, Sela S, Cohen H, Kristal B, Sbeit W, Reshef R. Effect of the antioxidant Mesna (2-mercaptoethane sulfonate) on experimental colitis. Dig Dis Sci. 2003;48(6):1177-1185.
35. Liu LN, Mei QB, Liu L, et al. Protective effects of Rheum tanguticum polysaccharide against hydrogen peroxide-induced intestinal epithelial cell injury. World J Gastroenterol. 2005;11(10):1503-1507.
36. Mahgoub AA, El-Medany AA, Hager HH, Mustafa AA, El-Sabah DM. Evaluating the prophylactic potential of zafirlukast against the toxic effects of acetic acid on the rat colon. Toxicol Lett. 2003;145(1):79-87.
37. Mabley JG, Pacher P, Liaudet L, et al. Inosine reduces inflammation and improves survival in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol. 2003;284(1):G138-144.
38. Cuzzocrea S, Mazzon E, Serraino I, et al. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res. 2001;30(1):1-12.
39. Kruidenier L, Kuiper I, van Duijn W, et al. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease. J Pathol. 2003;201(1):7-16.
40. Verspaget HW, Pena AS, Weterman IT, Lamers CB. Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut. 1988;29(2):223-228.